ÂÜÀòÂÒÂ×

In his former roles as physician and executive at the Mayo Clinic, Dr. Friese held executive positions for the $1 billion imaging service line, the Mayo Clinic Strategic Investment Fund, and Global Business Development, providing him with firsthand insight into cutting edge biomedical technologies and their impact on physicians, hospital systems, and their patients. With this insight he founded Verata Health, a healthcare AI company focused on technology to improve the prior authorization process for providers and payers. Verata was acquired by Olive AI (Columbus, OH) in December 2020. Current and prior board experience includes serving on the Scientific Advisory Board for Medtronic (2016-present), Ostra Cyber Security (2018-2020), the pharmacogenomics company OneOme (2014-2019), the International Monetary Fund (2016-2018), and Harvard Business School’s Healthcare Alumni Association (2017-2019).